Major Considerations in Early-Stage Translational Planning

Are you a company in early R&D or an individual involved in translational planning?

Join us for this informative webinar, presented by SRI International, where we'll discuss key development questions and considerations for companies in the early R&D stages that affect the likelihood of getting to critical value inflection points that enable late-phase clinical development or out-licensing.

We will provide an overview of the IND process and review specific tactics and strategies. Takeaways will include the benefits of such planning: